| Financial Year |
March 31 2023 |
| Monetary Funds |
6,809,287,620.24 |
| Held-for-trading Financial Assets |
2,400,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
240,646,700.66 |
| Advances to Suppliers |
95,608,981.36 |
| Other Receivables |
1,176,811,855.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
51,574,193,824.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,677,403,447.35 |
| Total Current Assets |
63,604,647,719.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,164,681,920.62 |
| Investment Properties |
657,428,514.27 |
| Fixed Assetes |
26,704,699.16 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,315,149.09 |
| R&D expenses |
-- |
| Goodwill |
7,856,648.51 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
589,061,833.33 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,798,217,446.30 |
| Total Assets |
67,402,865,166.23 |
| Short-Term Loans |
732,098,862.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,892,378,501.07 |
| Accounts Received In Advance |
18,033,084.67 |
| Employee Compensation Payable |
12,370,016.96 |
| Taxes Payable |
613,133,462.86 |
| Interest Payable |
-- |
| Dividend Payable |
2,503,502.30 |
| Other payables |
3,475,983,008.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,808,485,684.81 |
| Other Current Liabilities |
3,307,839,088.40 |
| Sub-Total of Current Liabilities |
49,614,244,111.97 |
| Long-term Loans |
5,948,780,000.00 |
| Bonds Payable |
383,740,193.92 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,187,625.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,351,019,199.60 |
| Total Liabilities |
55,965,263,311.57 |
| Paid-In Capital(Or Share Stock) |
3,183,922,485.00 |
| Capital Surplus |
-1,833,182,505.30 |
| Surplus Reserve |
599,482,598.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,880,594,196.07 |
| Minority Stockholder's Interest |
1,606,785,080.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,830,816,773.98 |
| Owner's Equity（Stockholder's Equity） |
11,437,601,854.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
67,402,865,166.23 |
